Ocugen

OCGN · NASDAQ

$0.8125+$0.0275 (+3.50%)TodayMarket closed · Oct 21, 4:05 AM ET

Prev close $0.785

About OCGN

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 116 full-time employees. The company went IPO on 2014-12-03. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. The company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. The company is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Employees: 116
Headquarters: Malvern, Pennsylvania
Listed: Dec 3, 2014
Sector: Health Care
Industry: Biotechnology
Website: ocugen.com

Leadership

Ocugen executives
Name	Title	Since	Age
Shankar Musunuri	—	2019	61
Ramesh Ramachandran	—	—	57
Arun Upadhyay	—	—	43
Huma Qamar	—	—	41
Kirsten Castillo	—	—	52
Uday Kompella	—	—	58
Junge Zhang	—	—	58
Tiffany Hamilton	—	2023	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Ocugen suppliers and customers
Company	Relationship	Country	Correlation
Jubilant Pharmova	Supplier and customer	IN	0.72
CanSino Biologics H	Supplier and customer	CN	0.67
MEDINET	Supplier and customer	JP	0.56
Massachusetts Eye & Ear Infirmary, Inc.	Supplier and customer	US	—
University of Colorado	Supplier and customer	US	—
Bharat Biotech International Ltd.	Supplier and customer	IN	—

Similar companies

Companies in the same industry as Ocugen

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.